Latest News
Get the latest in Alzheimer’s screening and treatments.
Blue light may damage the eyes by causing unstable “free radicals” to form, which increases the risk of age-related macular degeneration. BrightFocus-funded research offers a potential way to protect the eyes from blue light.
A BrightFocus-funded scientist is investigating a novel imaging tool that could be used to find treatable blood clots in the brain and slow the progression of Alzheimer’s disease.
Students and senior Alzheimer’s researchers gathered in Chicago for an immersive workshop hosted by BrightFocus Foundation.
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
"It's never too early in life or too late in life to reduce risk for dementia,” says Dr. Quincy Samus, a member of the Lancet Standing Commission on Dementia Prevention, Intervention, and Care. Learn more about two new ways to do so.
A new BrightFocus-funded study uncovers genetic clues that could point to new strategies for regrowing neurons in people living with glaucoma.
BrightFocus Foundation has received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants over the next three years as part of its Innovative Seed Funding Program.
Boosting research investment into the health and wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years, according to a RAND report commissioned by LuMind IDSC Foundation, the Alliance for Aging Research, BrightFocus Foundation, and the National Down Syndrome Society.
Can controlling blood pressure curb mid-life Alzheimer’s risk? A BrightFocus-funded scientist investigates.
